We have moved to new premises!

LS CancerDiag has new laboratory and office premises in Arabianranta, Helsinki During the Summer, LS CancerDiag moved to a new location in Helsinki. The new premises will serve as the global company headquarters and central

... read more

Meet our CSO, Dr. Minttu Kansikas

Minttu Kansikas, Ph.D., Chief Scientific Officer of LS CancerDiag, is one of the inventors of the method behind the DiagMMR test. She has been inspired by genetics since high school. She has enjoyed the field

... read more

Lynch syndrome in a nutshell

Lynch syndrome genetics and clinical implications The Gastroenterology journal (January 2023) features a review article by Professors Päivi Peltomäki, Minna Nyström, Jukka-Pekka Mecklin, and Toni T. Seppälä titled “Lynch Syndrome Genetics and Clinical Implications”. The

... read more

Invest today!

LS CancerDiag has launched a funding round in collaboration with Springvest

The company aims to raise €5.4M in capital to support the expansion into the United States and introduce DiagMMR® to the largest health care market in the world.